Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Aspart Injection vs NovoRapid in Diabetes
NCT02491528Phase 3Completed
- Sponsor
- Tonghua Dongbao
- Start
- Jun 2015
- Primary completion
- Aug 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin aspart in diabetes mellitus (DM), sponsored by Tonghua Dongbao. Started Jun 2015; status: completed.
02
Drugs
insulin aspart
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT02491528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02491528.